BLW
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E, PEG, Graham Number
- P/E of 9.91 is well below sector average of 30.45
- Price/Book of 0.98 suggests asset-backed valuation support
- Current price ($13.77) below Graham Number ($20.91)
- Price/Sales of 8.52 is high given negative revenue growth
- No Forward P/E or PEG to assess forward value
Ref Growth rates
- Earnings growth of 26.00% YoY and 36.00% QoQ indicates short-term earnings strength
- Revenue growth is negative (-3.40% YoY)
- No analyst targets or forward guidance available
- No PEG ratio due to missing growth-adjusted valuation
Ref Historical trends
- 1Y return of +6.4% and 5Y return of +34.9% outperform some peers
- Stock has traded in a narrow range near 52-week high
- 6M and 1M returns show decelerating momentum (+2.4%, +0.9%)
- Technical trend score of 0/100 indicates deteriorating price action
Ref Altman Z-Score, Piotroski F-Score
- Piotroski F-Score of 5/9 indicates stable financial condition
- Debt/Equity of 0.62 is below sector average of 1.64
- Current Ratio of 0.07 and Quick Ratio of 0.06 signal severe liquidity risk
- No Altman Z-Score available for distress risk modeling
- Missing Total Cash, Total Debt, and ROIC limits health assessment
Ref Yield, Payout
- High dividend yield of 9.86% is attractive
- Payout ratio of 97.73% is dangerously high
- Dividend Strength score of 40/100 indicates weak sustainability
- No 5-year yield average or ex-dividend date available
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for BLW and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
BLW
BlackRock Limited Duration Income Trust
Primary
|
+34.9% | +35.5% | +6.4% | +2.4% | +0.9% | +0.6% |
|
HQL
Abrdn Life Sciences Investors
Peer
|
+46.2% | +81.4% | +59.5% | +7.8% | +9.4% | -2.3% |
|
AROW
Arrow Financial Corporation
Peer
|
+14.4% | +38.0% | +30.5% | +14.0% | -7.1% | -2.9% |
|
BGB
Blackstone Strategic Credit 2027 Term Fund
Peer
|
+38.8% | +43.3% | +5.0% | -0.5% | +2.1% | -0.1% |
|
ECC
Eagle Point Credit Company Inc.
Peer
|
-12.0% | -31.3% | -32.2% | -25.4% | +13.0% | -0.7% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Services Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
BLW
BlackRock Limited Duration...
|
BEARISH | $533.36M | 9.91 | 9.9% | 81.9% | $13.77 | |
|
HQL
Abrdn Life Sciences Investors
|
BULLISH | $533.97M | 6.29 | 17.6% | 4415.7% | $17.56 | Compare |
|
AROW
Arrow Financial Corporation
|
NEUTRAL | $534.14M | 12.26 | 10.6% | 27.8% | $32.48 | Compare |
|
BGB
Blackstone Strategic...
|
BEARISH | $531.51M | 11.55 | -% | -% | $11.9 | Compare |
|
ECC
Eagle Point Credit Company Inc.
|
BEARISH | $531.48M | - | -11.2% | -56.4% | $4.02 | Compare |
Past News Coverage
Recent headlines mentioning BLW from our newsroom.